Phase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelisib, Everolimus, or Atirmociclib in ER+, HER2- Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Breast Cancer
Related studies linked through entity extraction aliases.
Guangzhou Women's Health Cohort Study (GWHCS)
- Status
- SUSPENDED
- Phase
- N/A
Study on the Safety and Efficacy of Autogenous Tumor Infiltrates Lymphocytes for the Treatment of Advanced Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- EARLY_PHASE1
Cryoablation vs Lumpectomy in T1 Breast Cancers
- Status
- RECRUITING
- Phase
- NA
Outcomes Among Patients in Brazil Receiving Palbociclib Combinations for HR+/HER2- MBC
- Status
- COMPLETED
- Phase
- N/A
A Phase Ib Study of HS-10352 Plus Fulvestrant in Patients With Advanced Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Protection of Cardiovascular Function With Crocin in BrEast Cancer Patients Undergoing Radiotherapy and Chemotherapy
- Status
- UNKNOWN
- Phase
- NA
Multidisciplinary Approach to Fatigue
- Status
- RECRUITING
- Phase
- NA
Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
CYP2D6 Genotypes and Breast Cancer Clinical Outcomes in the Indonesian Population
- Status
- UNKNOWN
- Phase
- NA
Oral AMXT 1501 Dicaprate in Combination With IV DFMO
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Breast Cancer With Intraoperative Radiotherapy Followed by Hypofractionated External Beam Radiotherapy
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Neoadjuvant Olaparib Monotherapy and Olaparib and Durvalumab Combination in HER2 Negative BRCAm Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
IMPACT Trial: Intervention to iMProve AdherenCe Equitably
- Status
- RECRUITING
- Phase
- NA
To Evaluate the Efficacy of Toripalimab Combined With Chemotherapy After HIFU Induction in the Treatment of Early Triple-negative Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Hypofractionated Radiotherapy in Breast Cancer Patients With Prosthetic Reconstruction
- Status
- RECRUITING
- Phase
- NA
Reinvigorating TNBC Response to Immunotherapy With Combination Myeloid Inhibition and Radiation
- Status
- RECRUITING
- Phase
- PHASE2
Treatment Patterns of Neratinib in HER2+ EBC in China
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
A Study of AC682 In Chinese Patients With ER+/HER2- Locally Advanced or Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1